HBM Healthcare Investments (Cayman) Ltd.'s Net Worth
Estimate Recalculated Nov 11, 2024 01:47PM EST
Who is HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. has an estimated net worth of $167 Million. This is based on reported shares across multiple companies, which include Mineralys Therapeutics, Inc., Nabriva Therapeutics Plc, Aspreva Pharmaceuticals CORP, , IO Biotech, Inc., Pacira Pharmaceuticals, Inc., Ophthotech Corp., PTC THERAPEUTICS, INC., Nabriva Therapeutics AG, Paratek Pharmaceuticals, Inc., Werewolf Therapeutics, Inc., ICAGEN INC, and MICRUS ENDOVASCULAR CORP.
SEC CIK
HBM Healthcare Investments (Cayman) Ltd.'s CIK is 0001232258
Past Insider Trading and Trends
2008 was HBM Healthcare Investments (Cayman) Ltd.'s most active year for acquiring shares with 211 total transactions. HBM Healthcare Investments (Cayman) Ltd.'s most active month to acquire stocks was the month of January. 2009 was HBM Healthcare Investments (Cayman) Ltd.'s most active year for disposing of shares, totalling 112 transactions. HBM Healthcare Investments (Cayman) Ltd.'s most active month to dispose stocks was the month of July. 2011 saw HBM Healthcare Investments (Cayman) Ltd. paying a total of $19,475,233.12 for 3,352,309 shares, this is the most they've acquired in one year. In 2014 HBM Healthcare Investments (Cayman) Ltd. cashed out on 500,000 shares for a total of $14,875,000.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
